Safety of statins when response is carefully monitored: A study of 336 heart recipients

Transplantation Proceedings

Volumn 37, Issue 9, 2005, Pages 4071-4073

  Marzoa Rivas, R ^a,e   Crespo Leiro, M G ^a,b   Paniagua Marin, M J ^a,b   Llinares Garcia D ^c   Muniz Garcia J ^d   Aldama Lopez G ^a   Pinon Esteban P ^a   Campo Perez R ^a   Castro Beiras, A ^b,d  

^a Área del Corazón ^*  (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Servicio de Medicina Interna   (Spain)

^d UNIVERSITY OF A CORUÑA   (Spain)

^e HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; BODY MASS; CONFERENCE PAPER; DIABETES MELLITUS; DIALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MONITORING; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; RISK FACTOR; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; ANTICHOLESTEREMIC AGENTS; BODY MASS INDEX; GRAFT REJECTION; HEART TRANSPLANTATION; HEPTANOIC ACIDS; HUMANS; MIDDLE AGED; OVERWEIGHT; PRAVASTATIN; PYRROLES; RETROSPECTIVE STUDIES; SAFETY;

EID: 29544433421     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.09.163     Document Type: Conference Paper

References (14)

1. L.W. Miller, R.C. Schlant, J. Kobashigawa 24th Bethesda Conference Task force 5 complications J Am Cardiol 22 1993 41
2. A.M. Keogh, H.A. Valantine, S.A. Hunt Impact of proximal or midvessel discrete coronary artery disease on survival after heart transplantation J Heart Lung Transplant 11 1992 892
3. J. Kobashigawa, S. Katznelson, H. Laks Effect of pravastatin on outcomes after cardiac transplantation N Engl J Med 333 1995 621
4. K. Wenke, B. Meiser, J. Thiery Simvastatin initiated early after heart transplantation 8-year prospective experience Circulation 107 2003 93
5. K. Wenke, B. Meiser, J. Thiery Simvastatin reduces graft vessel disease and mortality after heart transplantation a four-year randomized trial Circulation 96 1997 1398
6. A. Keogh, P. Macdonald, A. Kaan Efficacy and safety of pravastatin vs. simvastatin after cardiac transplantation J Heart Lung Transplant 19 2000 529
7. M.R. Mehra, P.A. Uber, K. Vivekananthan Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival J Am Coll Cardiol 40 2002 1609
8. G. Magnani, V. Carinci, C. Magelli Role of statins in the management of dyslipemia after cardiac transplant randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin J Heart Lung Transplant 19 2000 710
9. D.N. Patel, F.D. Pagani, T.M. Koelling Safety and efficacy of atorvastatin in heart transplant recipients J Heart Lung Transplant 21 2002 204
10. J.A. Rodriguez, M.G. Crespo-Leiro, M.J. Paniagua Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine Transplant Proc 31 1999 2522
11. L. Martínez-Dolz, L. Almenar, V.A. Arnau Utility of pravastatin in cardiac transplant dyslipdemia Rev Clin Esp 202 2002 489
12. P.D. Thompson, P. Clarkson, R.H. Karas Statin-associated myopathy JAMA 289 2003 1681
13. R. Pasternak, S. Smith, N. Barrey-Merz ACC/AHA/NHLBI clinical advisory on the use and safety of statins J Am Coll Cardiol 40 2002 567
14. K.C. Bilchick, C.A. Henrikson, D. Skojec Treatment of hyperlipidemia in cardiac transplant recipients Am Heart J 148 2004 200